Welcome to our dedicated page for COSTAS news (Ticker: CSSI), a resource for investors and traders seeking the latest updates and insights on COSTAS stock.
Costas Inc (CSSI), operating as Standard Dental Labs Inc., is a construction company based in Orlando, Florida, specializing in dental lab services. The company's core business includes manufacturing dental implants, prosthetics, and other dental products, with a focus on acquiring and consolidating dental labs in the Orlando area. Costas Inc aims to drive growth through acquisitions and is strategically positioned to capitalize on the booming dental industry in Florida.
Standard Dental Labs (OTCMKTS: CSSI) announces two significant developments: near completion of FINRA compliance process and filing of a Tier 2 Regulation A offering. The company has worked with FINRA since March to restore compliance standing, demonstrating commitment to regulatory integrity. The Tier 2 offering, allowing up to $75 million in fundraising over 12 months, aims to address cash flow needs and support expansion in Florida's dental lab market.
CEO James Brooks highlighted these achievements as important milestones following three quarters of addressing operational and financial challenges. The company has collaborated with the SEC, securities counsel, CPAs, and auditors to ensure financial diligence while pursuing its strategy to acquire additional dental laboratories in Florida.
Costas, Inc. (CSSI), operating as Standard Dental Labs, is actively pursuing acquisitions of dental labs in Orlando following its successful acquisition of Prime Dental Lab in August 2022. With an aim to consolidate these facilities into a "Mega Lab," the company has resumed discussions with interested lab owners. Recent communications indicate that five additional lab owners are eager to negotiate with Standard Dental Labs. CEO James Brooks highlights the opportunity presented by retiring baby boomers, stating that many own dental labs. The strategic goal is to grow through acquisitions and expand revenue in the increasingly consolidating dental industry.
ORLANDO, FL / ACCESSWIRE / January 31, 2023 / Costas, Inc. (OTC PINK:CSSI) reflects on 2022 milestones post-CEO James Brooks' appointment. Key achievements include acquiring assets from Standard Dental Labs in March 2022, establishing a focus on acquiring cash-flowing dental labs, and generating its first revenue in 20 years following the Prime Dental Lab acquisition. The dental lab market is valued at $10B in the U.S., and CSSI aims to purchase up to 20 labs in 2023. The company plans to consolidate operations in Orlando, ensuring future revenue growth while emphasizing the need for a strong management team to support its expansion strategy.
Costas, Inc. (OTC PINK:CSSI) reports Q3 2022 gross revenues of $44,770, attributed to its acquisition of assets from Prime Dental Labs effective September 1, 2022. This marks the Company's first revenues under new management. The company has also filed a supplemental notice indicating it is no longer a 'Shell Company.' Furthermore, it aims to acquire additional dental labs in Orlando, positioning itself in a US dental lab market projected at $10B, with plans for consolidation into larger operational facilities.
Costas, Inc. (CSSI) has engaged an Independent Registered Public Accounting Firm to audit its financial results for the fiscal years 2021 and 2020, and for the six-month interim periods ending June 30, 2022, and 2021. This follows the recent agreement to acquire Prime Dental Lab LLC's assets. The audits will adhere to US GAAP, focusing on revenue recognition. The company aims to become a fully reporting issuer with the SEC and plans to complete audits to file a Form S-1 Registration. The dental lab market is expected to grow to $43.5 billion by 2028, presenting acquisition opportunities for CSSI.
Costas, Inc. (OTC PINK:CSSI) has finalized an agreement to acquire Prime Dental Lab, LLC, an Orlando-based dental lab with over a decade of operation and 2021 unaudited gross revenue surpassing $600,000. The deal, valued at $700,000, will be executed through a mix of cash and registered shares, with shares held in escrow for two years. This acquisition aligns with CSSI's strategy to consolidate dental labs for operational efficiencies within the $10B U.S. dental lab market, focusing on cash-flowing and profitable businesses.
FAQ
What is the current stock price of COSTAS (CSSI)?
What is the market cap of COSTAS (CSSI)?
What is Costas Inc's primary business focus?
How does Costas Inc plan to grow its business?
What is the core strategy of Costas Inc?
Where is Costas Inc headquartered?
What sets Costas Inc apart in the dental industry?
How does Costas Inc contribute to the dental healthcare sector?
What is the mission of Costas Inc?
What is the significance of the retirement succession program offered by Costas Inc?
How can dental lab owners benefit from partnering with Costas Inc?